Multivariable analysis in this study suggested that TIL levels were an independent prognostic factor for patients with HER-2-positive BC; however, the direct association with HER-2 expression may be influenced by tumor heterogeneity or microenvironmental regulatory factors. Here, ERBB2 is linked to breast cancer.